Clinical optimization and molecular characterization of an engineered Type-1 regulatory T cell therapy
Ontology highlight
ABSTRACT: purpose: To investigate transcriptional changes in engineered Tr1 Cells Methods: RNA sequencing of polyA enriched donor matched CD4 T cells lentiviral transduced with human IL-10 (CD4IL-10) or control GFP (CD4GFP) Results: 142 total DEGs were identified as differentially expressed between CD4IL-10 and CD4GFP. GEO analysis found highest enrichment in genes related to cytokine signaling and cytotoxicity. Conclusion: Engineered Tr1 cells upregulate primarily cytotoxicity related effector molecules related to the myeloid cell killing phenotype observed in Tr1 cells
ORGANISM(S): Homo sapiens
PROVIDER: GSE162915 | GEO | 2021/12/08
REPOSITORIES: GEO
ACCESS DATA